Zobrazeno 1 - 6
of 6
pro vyhledávání: '"O A, Shukhov"'
Publikováno v:
Терапевтический архив, Vol 92, Iss 7, Pp 90-94 (2020)
Therapy with tyrosine kinase inhibitors (TKI) allows to achieve a deep molecular response in 6070% of patients with chronic myeloid leukemia (CML). According to the current guidelines CML patients receive a long-term treatment with TKI in standard do
Externí odkaz:
https://doaj.org/article/4612f90d3bd9452f95daf6025e11e77c
Autor:
F. Khadadah, A. G. Turkina, E. Lomaia, E. V. Morozova, O. A. Shukhov, A. Petrova, T. Chitanava, J. J. Vlasova, E. Kuzmina, I. Nemchenko, E. Y. Chelysheva, A. Bykova, M. Gurianova, A. Xenocostas, L. Busque, K. Jamani, S. Cerquozzi, P. Kuruvilla, R. Kaedbey, B. Leber, S. Assouline, D. D. H. Kim
Publikováno v:
HemaSphere, Vol 6, Pp 603-604 (2022)
Externí odkaz:
https://doaj.org/article/01f4abc94f7946a591cfb1b305f0cebe
Autor:
A G Turkina, E Yu Chelysheva, V A Shuvaev, G A Gusarova, A V Bykova, O A Shukhov, A N Petrova, M V Vakhrusheva, S R Goryacheva, L Yu Kolosova, P S Krasikova, M S Fominykh, I S Martynkevich, A O Abdullaev, A B Sudarikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 12, Pp 86-96 (2017)
Aim. To assess the results of following up patients with chronic myeloid leukemia (CML) and a deep molecular response (MR) without tyrosine kinase inhibitor (TKI) therapy. Subjects and methods. The reasons for TKI discontinuation in 70 patients with
Externí odkaz:
https://doaj.org/article/a5d61a4d5cc34f2caccd0b415e5af767
Autor:
M A Sokolova, A G Turkina, A L Melikian, A B Sudarikov, S A Treglazova, O A Shukhov, E G Gemdzhian, A О Abdullaev, A M Kovrigina, A V Misyurin, Yu V Pliskunova, V L Ivanova, T N Moiseeva
Publikováno v:
Терапевтический архив, Vol 88, Iss 12, Pp 69-77 (2016)
Aim. To evaluate the efficiency of interferon (IFN) therapy in patients with essential thrombocythemia (ET) and polycythemia vera (PV). Subjects and methods. A total of 61 patients (41 with ET and 20 with PV) were examined. Prior to study enrolment,
Externí odkaz:
https://doaj.org/article/5309a997ecb44a6ca0be0a7552cb71f1
Autor:
S. A. Smirnikhina, G. A. Tsaur, E. Yu. Chelysheva, Yu. A. Yakovleva, A. V. Lavrov, A. O. Аbdullaev, N. V. Bederak, O. A. Shukhov, A. G. Solodovnikov, A. M. Popov, E. P. Adilgereeva, L. G. Fechina, A. G. Turkina, S. I. Kutsev
Publikováno v:
Онкогематология, Vol 8, Iss 3, Pp 16-21 (2014)
Key words: chronic myeloid leukemia, BCR-ABL expression, automated GeneXpert method
Externí odkaz:
https://doaj.org/article/fcc7ce1a23bb494d9d30fb913afcc27b
Autor:
N A, Petinati, I N, Shipounova, E A, Fastova, A U, Magomedova, S K, Kravchenko, E Yu, Chelysheva, O A, Shukhov, A G, Turkina, N V, Sats, N I, Drize, E N, Parovichnikova, V G, Savchenko
Publikováno v:
Bulletin of experimental biology and medicine. 171(4)
Multipotent mesenchymal stromal cells (MSC) are the key regulators of hematopoiesis. We studied changes in MSC characteristics in patients with myeloid leukemia and patients with lymphoproliferative diseases. MSC were obtained from the bone marrow of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::da627663eea8a58257d6ea0593830cf4
https://pubmed.ncbi.nlm.nih.gov/34542753
https://pubmed.ncbi.nlm.nih.gov/34542753